Status:
UNKNOWN
The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease
Lead Sponsor:
Meir Medical Center
Conditions:
Interstitial Lung Disease
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
We hypothesized that the multi-disciplinary assessment of interstitial lung disease patients would lead to a more accurate diagnosis and consequently alterations in treatment regimens that may lead to...
Eligibility Criteria
Inclusion
- Age above 18 years old
- ILD according to ATS/ERS guidelines
- Signed inform consent
Exclusion
- Previous lung surgery
- Other significant systemic disease
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2016
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01809574
Start Date
May 1 2013
End Date
March 1 2016
Last Update
April 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel, Israel, 972